The promise and reality of fixed-dose combinations with rifampicin. A joint statement of the International Union Against Tuberculosis and Lung Disease and the Tuberculosis Programme of the World Health Organization

Tuber Lung Dis. 1994 Jun;75(3):180-1. doi: 10.1016/0962-8479(94)90004-3.
No abstract available

Publication types

  • Guideline
  • Practice Guideline

MeSH terms

  • Biological Availability
  • Drug Combinations
  • Humans
  • Rifampin / pharmacokinetics*
  • Rifampin / therapeutic use
  • Societies, Medical
  • Tuberculosis / drug therapy
  • Tuberculosis / metabolism*
  • World Health Organization

Substances

  • Drug Combinations
  • Rifampin